ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare
CEO John Maraganore sold $3.9M of Alnylam Pharmaceuticals, Inc.
Sold$3,929,210
$79.45Price
49,456Shares
−20%Stake
What ALNY did after the filing
- The stock from Thu, Oct 17 open, $81.99
- +42.9%
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Nov 29 close.
Traded Mon, Oct 14. Filed Wed, Oct 16, 4:06 PM ET, after the close. Returns use the Oct 17 open and the Nov 29 close. Not investment advice.